Matrixx Initiatives Inc. (MTXX): INO.COM has a 100 score on the trend for...

pinoleropuro · 2009-09-22T04:59:50.5530000Z

INO.COM has a 100 score on the trend for this one last hr close above 5hr moving average new three day high on monday last price above 20 day moving average new three week high, week ending August 29th new three month high in June Stoxline.com has a buy signal on MTXX and also a 6 month target of 7.97/share and a year target of 9.30/share I am no expert but it looks pretty good to me.

Play Episode

6min

Proactive - Interviews for investors

Lisata Therapeutics CMO discusses potential for certepetide under Catalent license agreement

Lisata Therapeutics Inc (NASDAQ:LSTA) chief medical officer Dr Kristen Buck discussed the company's newly-announced research license agreement with Catalent with Proactive's Stephen Gunnion. Buck shared insights into Lisata’s preclinical evaluation of certepetide using Catalent’s SMARTag antibody-drug conjugate (ADC) platform.. She explained that Catalent would assume all R&D costs, while Lisata provides consulting and stands to receive both upfront and potential milestone payments. Certepetide is described as a unique cyclic non-amino acid peptide, designed to bind to receptors commonly found on solid tumors. Upon binding, it transforms to activate a transport mechanism that boosts therapeutic penetration. "It can work with current therapies and emerging therapies," Buck said, emphasizing its compatibility and favorable safety profile. Buck further discussed the growing relevance of ADCs in oncology. She described ADCs as “biological missiles,” targeting tumors while minimizing harm to healthy tissues. When combined with certepetide, ADCs benefit from deeper tumor penetration and potential immunomodulation, making treatment more effective. The company expects initial data from this collaboration before the end of Q2 2025. Positive results could lead to a deeper relationship with Catalent. Visit Proactive's YouTube channel for more company interviews and updates. Don’t forget to like this video, subscribe to the channel, and enable notifications so you never miss future content. #LisataTherapeutics #KristenBuck #Certepetide #AntibodyDrugConjugates #ADC #OncologyInnovation #CancerResearch #Catalent #BiotechNews #TumorTargeting #ImmunoOncology #SMARTagPlatform

Proactive - Interviews for investors

Liberty Star Minerals engages lawmakers in D.C. to champion U.S. investment in critical minerals

Liberty Star Minerals Chairman Pete O’Heeron and Director Gerardo King joined Steve Darling from Proactive to provide an update on their recent trip to Washington, D.C. this week for a series of high-level meetings with Congressional offices to discuss the urgent need for U.S. investment in the exploration and development of critical minerals. The company’s leadership sat down with influential policymakers, including Senators Ted Cruz and John Cornyn, to emphasize the strategic importance of securing domestic sources of minerals essential to national security, clean energy, and technological innovation. “The United States is at a critical juncture in ensuring the security of its supply chain for critical minerals,” said Chairman Pete O’Heeron. “We can no longer afford to rely on foreign nations for the materials that power everything from smartphones to fighter jets. It’s imperative that the U.S. government take a leadership role in funding and incentivizing domestic mineral exploration. Liberty Star Minerals is ready to be part of that solution.” The discussions highlighted the urgent need for a coordinated national effort to support projects like Liberty Star’s Hay Mountain Project in southeast Arizona—one of the most promising undeveloped mineral properties in the U.S. The project targets a diverse range of high-demand strategic metals including copper, lithium, and rare earth elements, which are vital to the defense sector, the transition to clean energy, and the advancement of next-generation technologies. #proactiveinvestors #libertystarminerals #otc #lbsr #redrockcanyon #arizona #LibertyStarMinerals #USMining #StrategicMetals #CopperExploration #GoldOutlook #DomesticResources #MineralSupplyChain #ProactiveInvestors

Proactive - Interviews for investors

The Vaccine Group teams up with animal health giant Syva on breakthrough pig vaccine

Jeremy Salt, CEO of The Vaccine Group (TVG), a Frontier IP Group PLC portfolio company, talked with Proactive's Stephen Gunnion about the company’s collaboration with global animal health firm Syva. Salt explained that the partnership focuses on developing a vaccine for Streptococcus suis, a major disease in pigs that also contributes significantly to the use of antibiotics in livestock farming. “One of the key aspects of this collaboration with them is that they have a significant gap in their portfolio of products for pigs,” Salt noted. He emphasised that Streptococcus suis is prevalent in around 60% of European countries and impacts pig farming worldwide, with antimicrobial resistance (AMR) being a critical concern. The zoonotic nature of the disease, particularly in Southeast Asia, adds another layer of urgency to develop effective solutions. Salt highlighted that TVG’s vaccine platform provides broader protection across multiple strains, making it potentially globally applicable. The vaccine can be administered to young piglets, which is strategically important and is also expected to be more cost-effective than conventional options. He also discussed the role of UK government support, with Innovate UK and DEFRA grants contributing around £1 million in funding. The company is also progressing with 12 vaccine candidates, including developments in poultry and biotherapeutics delivery using monoclonal antibodies. For more updates, visit Proactive's YouTube channel. Don't forget to like the video, subscribe to the channel, and turn on notifications for future content. #AnimalHealth #Vaccines #SwineIndustry #AntimicrobialResistance #BiotechNews #TVG #FrontierIP #ProactiveInvestors #PigHealth #ZoonoticDiseases #LivestockFarming #VeterinaryInnovation #MonoclonalAntibodies #PoultryVaccines #Biotherapeutics

Proactive - Interviews for investors

Pantheon Resources provides update on MEGREZ-1 flow testing results

Pantheon Resources Chairman David Hobbs and CEO Max Easley joined Steve Darling from Proactive to share preliminary flow test results from the Megrez-1 well in Alaska. The well is part of a six-interval testing program, and the first interval tested, the Topset 1 (TS1) reservoir, was fracture stimulated across 290 feet between 7,165 and 7,453 feet measured depth (MD). The well produced sustained strong liquid rates for 12 days, exceeding 1,000 barrels per day by the end of the flow-back period. However, no appreciable hydrocarbons were recovered during this initial test. Despite this, Easley noted the data reveals the TS1 reservoir is oil bearing but likely located within a transition zone that contains limited to no mobile oil or gas. Importantly, the technical data gathered from this interval has boosted the company's confidence in the five remaining, shallower intervals still to be tested. These higher zones are believed to hold greater potential for mobile hydrocarbons and increased productivity. TS1 will now be abandoned, and preparations are underway to begin testing the Lower Prince Creek interval. High-pressure pumping equipment is currently being mobilized to the Megrez pad. While the initial result may seem underwhelming at first glance, Pantheon emphasized that it strengthens their geological model and supports the likelihood of commercial success in the intervals yet to be tested. #proactiveinvestors #pantheonresourcesplc #mining #lse #panr #pthrf #OilAndGas #MEGREZ1 #FlowTesting #EnergyExploration #Hydrocarbons #AlaskaOil #OilDrilling #ResourceDevelopment #OilfieldUpdate

Followers	19
Posts	479
Boards Moderated	0
Alias Born	09/24/2007

Volume:	-
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

MTXX Detailed Quote

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Go Ad-Free